J Neurooncol  2020 May;147(3):525-529. doi: 10.1007/s11060-020-03488-7. Epub 2020 Apr 9.

Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology

Rohan Ramakrishna ¹, Gelareh Zadeh ², Jason P Sheehan ³, Manish K Aghi ⁴Affiliations expand

• PMID: 32274630
• PMCID: PMC7145274
• DOI: 10.1007/s11060-020-03488-7

Free PMC article

Abstract

The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease.

Keywords: Acoustic neuroma; Brain metastasis; COVID19; Coronavirus; Endoscopic endonasal; Glioblastoma; Glioma; Meningioma; Neuro-oncology; Neurosurgery; SARS-CoV-2; Skull base.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145274/

Conflict of interest statement

The authors have no relevant conflicts of interest.

Similar articles

• Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic.Hu YJ, Zhang JM, Chen ZP.J Neurooncol. 2020 May;148(1):199-200. doi: 10.1007/s11060-020-03489-6. Epub 2020 Apr 10.PMID: 32277378 Free PMC article. No abstract available.